AQR Capital Management’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $397K | Sell |
174,006
-15,505
| -8% | -$49.2K | ﹤0.01% | 3255 |
|
|
2025
Q4 | $758K | Buy |
189,511
+171,010
| +924% | +$951K | ﹤0.01% | 2701 |
|
|
2025
Q3 | $157K | Sell |
18,501
-2,207
| -11% | -$21.4K | ﹤0.01% | 3307 |
|
|
2025
Q2 | $233K | Buy |
20,708
+9,411
| +83% | +$86.4K | ﹤0.01% | 2984 |
|
|
2025
Q1 | $107K | Sell |
11,297
-657
| -5% | -$6.64K | ﹤0.01% | 3002 |
|
|
2024
Q4 | $134K | Buy |
11,954
+4,762
| +66% | +$83.7K | ﹤0.01% | 2733 |
|
|
2024
Q3 | $203K | Buy |
+7,192
| New | +$185K | ﹤0.01% | 2563 |
|
|
2024
Q2 | – | Sell |
-6,977
| Closed | -$229K | – | 2621 |
|
|
2024
Q1 | $229K | Buy |
6,977
+234
| +3% | +$7.47K | ﹤0.01% | 2224 |
|
|
2023
Q4 | $223K | Sell |
6,743
-4,411
| -40% | -$125K | ﹤0.01% | 2175 |
|
|
2023
Q3 | $304K | Sell |
11,154
-10,890
| -49% | -$303K | ﹤0.01% | 2006 |
|
|
2023
Q2 | $668K | Sell |
22,044
-925
| -4% | -$29.9K | ﹤0.01% | 1706 |
|
|
2023
Q1 | $745K | Sell |
22,969
-54,806
| -70% | -$1.73M | ﹤0.01% | 1640 |
|
|
2022
Q4 | $2.18M | Sell |
77,775
-7,827
| -9% | -$224K | 0.01% | 1216 |
|
|
2022
Q3 | $3.08M | Buy |
85,602
+22,402
| +35% | +$789K | 0.01% | 1017 |
|
|
2022
Q2 | $1.94M | Buy |
63,200
+12,734
| +25% | +$371K | ﹤0.01% | 1110 |
|
|
2022
Q1 | $1.63M | Buy |
50,466
+13,383
| +36% | +$350K | ﹤0.01% | 1303 |
|
|
2021
Q4 | $1.03M | Buy |
37,083
+1,995
| +6% | +$57.2K | ﹤0.01% | 1549 |
|
|
2021
Q3 | $1.09M | Sell |
35,088
-1,676
| -5% | -$40.2K | ﹤0.01% | 1488 |
|
|
2021
Q2 | $776K | Sell |
36,764
-5,306
| -13% | -$106K | ﹤0.01% | 1691 |
|
|
2021
Q1 | $850K | Sell |
42,070
-61,566
| -59% | -$1.17M | ﹤0.01% | 1622 |
|
|
2020
Q4 | $1.66M | Buy |
103,636
+85,059
| +458% | +$1.12M | ﹤0.01% | 1259 |
|
|
2020
Q3 | $231K | Buy |
+18,577
| New | +$218K | ﹤0.01% | 2010 |
|
|
2020
Q1 | – | Sell |
-16,371
| Closed | -$148K | – | 2074 |
|
|
2019
Q4 | $148K | Buy |
+16,371
| New | +$133K | ﹤0.01% | 2044 |
|
|
2019
Q3 | – | Sell |
-10,609
| Closed | -$84K | – | 2122 |
|
|
2019
Q2 | $84K | Sell |
10,609
-16,314
| -61% | -$193K | ﹤0.01% | 2045 |
|
|
2019
Q1 | $339K | Buy |
26,923
+427
| +2% | +$6.76K | ﹤0.01% | 1929 |
|
|
2018
Q4 | $529K | Buy |
+26,496
| New | +$613K | ﹤0.01% | 1754 |
|
|
2017
Q3 | – | Sell |
-34,004
| Closed | -$862K | – | 2251 |
|
|
2017
Q2 | $862K | Buy |
34,004
+360
| +1% | +$8.66K | ﹤0.01% | 1723 |
|
|
2017
Q1 | $750K | Buy |
33,644
+7,987
| +31% | +$153K | ﹤0.01% | 1758 |
|
|
2016
Q4 | $380K | Buy |
25,657
+14,723
| +135% | +$290K | ﹤0.01% | 2000 |
|
|
2016
Q3 | $269K | Buy |
+10,934
| New | +$256K | ﹤0.01% | 2105 |
|
Other funds holding EVH
CCM
RF
EC
VCM
RSCM
AQR Capital Management's EVH Position: Q1 2026 in Review
AQR Capital Management reduced its Evolent Health (EVH) stake by 8.2% in Q1 2026, selling an estimated $49.2K and leaving 174,006 shares worth $397K. The position accounts for ﹤0.01% of the portfolio, ranked #3255.
AQR Capital Management first reported a position in EVH in Q3 2016 and has held it in 30 quarters since. The position peaked at $3.08M in Q3 2022. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.
- AQR Capital Management held 174,006 shares of Evolent Health worth $397K as of Q1 2026.
- AQR Capital Management sold 15,505 Evolent Health shares in Q1 2026, an estimated $49.2K.
- Evolent Health made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #3255 holding.
- AQR Capital Management first reported a position in Evolent Health in Q3 2016 and has held it in 30 quarters since.
- AQR Capital Management's Evolent Health position peaked at $3.08M in Q3 2022.
- 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.
Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.